In this episode of Whimsical Wavelengths, Dr. Jeffrey Zurek sits down with Dr. Katherine Borden, a professor at Northwestern University's Feinberg School of Medicine, to explore the ancient and vital protein eIF4E (or 4E). Long misunderstood as a simple rate-limiting factor in protein synthesis, 4E acts as a master regulator of RNA processing, transport, and translation. Dr. Borden shares the serendipitous discovery of finding 4E in the cell nucleus, how cancer cells hijack this machinery to drive aggressive disease states like acute myeloid leukemia (AML), and the ongoing journey of translating basic science into clinical trials using repurposed antivirals.

Sub-Themes and Highlights

The Research Process and Serendipity: How a control experiment looking for viral interactions led to a major paradigm shift in understanding 4E’s nuclear localization.

Social Impacts and Translational Health: Exploring the challenges of drug resistance, glucuronidation, and the human side of clinical trials for heavily pretreated patients.

Community and Collaboration: Highlighting the Canadian Sciences Speakers Network (CSSN) as a vital tool for connecting researchers, media, and the public beyond traditional word-of-mouth networks.

Chapters

• 00:00 Introducing eIF4E
• 02:12 Discovering the CSSN network.
• 03:45 Meeting Dr. Katherine Borden.
• 07:55 Cellular stress and paper cuts.
• 10:48 Evolution of 4E research.
• 17:05 The nuclear eureka moment.
• 19:18 The Goldilocks protein zone.
• 21:45 Ribavirin clinical trials.
• 26:15 The biology of drug resistance.
• 33:10 The tumor microenvironment.
• 36:30 Future outlook on therapy.
• 38:50 Patient thanks and atom jokes.

Links:

Web: WhimsicalWavelengths.com

Support: Pateron

Socials: Bluesky | Instagram | Facebook

Whimsical Wavelengths: Deep-dive conversations where a working scientist unpacks how we know what we know, one paper, one idea, or whimsical detour at a time. Hosted by Dr. Jeffrey Zurek (P.Geo).

Hey! I'd love to hear your thoughts, send me a voice note.